Potential Drug Shortage: Hydroxyurea

There are three suppliers of hydroxyurea capsules in the Canadian marketplace.

The Apotex brand is currently on backorder with no estimated return date. The Mylan brand is currently on backorder with an estimated return date of October 11, 2019. The Bristol-Myers Squibb brand is currently on allocation, with an estimated end date of November 29, 2019.

There are variable supplies remaining at BC Cancer Centres and Community Oncology Network (CON) sites, and hydroxyurea capsules may run out prior to the release dates.

Further information and practice implications.